Company / Cash per Share
Fortress Biotech, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.84
FY2025
5-year range
$1.76 / $10.99
FY2021-FY2025
Trend
-25.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $1.28 in FY2018 to $10.99 in FY2023.
Based on SEC 10-K filings.
2.84 in FY2025 with a 5-year CAGR of +9.0%.
Declined from $10.99 to $2.84 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 25.0% year-over-year.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.84 | -25.0% |
| FY2024 | $3.79 | -65.5% |
| FY2023 | $10.99 | +525.1% |
| FY2022 | $1.76 | -45.5% |
| FY2021 | $3.22 | +74.3% |
| FY2020 | $1.85 | -21.9% |
| FY2019 | $2.37 | +84.2% |
| FY2018 | $1.28 | -28.8% |
| FY2017 | $1.80 | -13.4% |
| FY2016 | $2.08 | -2.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026